The effect of measles vaccination in rhesus monkeys (Macaca mulatta)

Laboratory Animals
|July 1, 1982
PubMed

Insights

Infants under six months show poor response to measles vaccination. However, re-vaccination at 8-10 months significantly boosts measles virus antibody levels in young rhesus monkeys.

Area of Science:

  • Veterinary Immunology
  • Virology
  • Primate Research

Background:

  • Measles vaccination is crucial for preventing disease outbreaks.
  • Understanding optimal vaccination timing in non-human primates is essential for research models.

Purpose of the Study:

  • To evaluate the immunogenicity of measles vaccination in rhesus monkeys at different ages.
  • To assess the efficacy of revaccination in young animals.

Main Methods:

  • Thirty rhesus monkeys received primary measles vaccination at 3-26 months of age.
  • Antibody levels were measured using haemagglutination-inhibition assays.
  • Animals were re-vaccinated 5-7 months later, with antibody levels reassessed.

Main Results:

  • Only 2 of 9 monkeys under 6 months responded to initial vaccination.
  • 10 of 14 older monkeys (age not specified but >6 months) showed a significant antibody rise.
  • Re-vaccination of the younger group at 8-10 months induced a marked antibody increase.

Conclusions:

  • Rhesus monkeys under 6 months of age have a limited response to measles vaccination.
  • Re-vaccination is effective in eliciting a robust antibody response in younger animals at a later age.
  • Age is a critical factor influencing measles vaccine efficacy in rhesus monkeys.